Lipid deposition promotes YTHDF3-mediated m6A modification of PPARα to facilitate liver metastasis of colorectal cancer
Protein & Cell · 2026
DOI: 10.1093/procel/pwaf092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2026. Verfasst von Wen Ni und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, RNA-Binding Proteins, PPAR alpha. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
The liver is a common site for cancer metastasis and a key metabolic organ. Lipid metabolism irregularities are linked to liver metastasis risk, but the mechanisms are not fully understood. Herein, in colorectal cancer liver metastasis (CRLM) clinical samples, lipid metabolism was broadly dysregulated, and lipid metabolites accumulated, as shown by integrated transcriptome and lipidomics analyses. Functionally, lipid deposition promotes liver metastasis in vitro and in vivo. Mechanistically, lipid deposition significantly enhances YTHDF3-mediated m6A modification and degradation of PPARα, which is crucial for liver metastasis. This process reduces the β-hydroxybutyrylation of YTHDF3, thereby promoting LLPS and increasing the stability of YTHDF3, which in turn facilitates the progression of CRC and liver metastasis. Furthermore, lipid deposition induces the interaction between STAT3 and YAP, activating YTHDF3 transcription. These two regulatory mechanisms synergize to drive YTHDF3 accumulation in lipid-rich metastatic lesions. In summary, our findings reveal that lipid deposition promotes LLPS-mediated m6A modification and decreases β-hydroxybutyrylation in liver metastasis, offering new strategies for the treatment of CRLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
- Department of Hepato-Billiary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
- Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China.
- The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
- Department of Pathology and Institute of Molecular Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
ORCID-Profile: Jianming Li
Förderung
- National Natural Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Ni, W., Xu, Y., Zhang, M., Li, Y., Huang, P., Li, Z., Wu, Q., Mo, H., Ye, Y., Li, Y., Zhou, A., Yao, S., Zhi, S., Qi, J., Yu, S., He, S., & Li, J. (2026). Lipid deposition promotes YTHDF3-mediated m6A modification of PPARα to facilitate liver metastasis of colorectal cancer. Protein & Cell. https://doi.org/10.1093/procel/pwaf092
Vancouver
Ni W, Xu Y, Zhang M, Li Y, Huang P, Li Z, et al. Lipid deposition promotes YTHDF3-mediated m6A modification of PPARα to facilitate liver metastasis of colorectal cancer. Protein & Cell. 2026. doi:10.1093/procel/pwaf092
BibTeX
@article{Ni2026,
author = {Ni, Wen and Xu, Yuanyuan and Zhang, Mengrou and Li, Yuqing and Huang, Piao and Li, Zhun and Wu, Qi and Mo, Hui and Ye, Yibiao and Li, Yuhui and Zhou, Aijun and Yao, Su and Zhi, Shilin and Qi, Jiali and Yu, Shuhui and He, Saiqi and Li, Jianming},
title = {Lipid deposition promotes YTHDF3-mediated m6A modification of PPARα to facilitate liver metastasis of colorectal cancer},
journal = {Protein & Cell},
year = {2026},
doi = {10.1093/procel/pwaf092}
}
EUVIMED